Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082754 | Drug Discovery Today: Technologies | 2011 | 8 Pages |
Abstract
Recent developments of fluorescent probes beyond approved indocyanine green (ICG) - itself increasingly spreading into new imaging applications like lymphatic mapping, arthritis imaging and tumor surgery - exploit various photophysical and biochemical mechanisms to monitor molecular events with higher specificity and accuracy. Emphasizing nanoparticulate formulations, targeted conjugates, activatable probes, probes with a sensor function and multimodality probes, this review discusses advantages and limitations of each type of probe, thereby critically assessing the desired translation into the clinic.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Kai Licha, Ute Resch-Genger,